APA (7th ed.) Citation

Bajaj, H., Brown, R., Bhullar, L., Sohi, N., Kalra, S., & Aronson, R. (2018). SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes. Diabetes & metabolism, 44(6), 493-499. https://doi.org/10.1016/j.diabet.2018.08.001

Chicago Style (17th ed.) Citation

Bajaj, H.S, R.E Brown, L. Bhullar, N. Sohi, S. Kalra, and R. Aronson. "SGLT2 Inhibitors and Incretin Agents: Associations with Alanine Aminotransferase Activity in Type 2 Diabetes." Diabetes & Metabolism 44, no. 6 (2018): 493-499. https://doi.org/10.1016/j.diabet.2018.08.001.

MLA (9th ed.) Citation

Bajaj, H.S, et al. "SGLT2 Inhibitors and Incretin Agents: Associations with Alanine Aminotransferase Activity in Type 2 Diabetes." Diabetes & Metabolism, vol. 44, no. 6, 2018, pp. 493-499, https://doi.org/10.1016/j.diabet.2018.08.001.